4//SEC Filing
Johnson Anne Nagengast 4
Accession 0001140361-24-018029
CIK 0001840904other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:11 PM ET
Size
4.5 KB
Accession
0001140361-24-018029
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Sale
Common Shares
2024-04-02$1.85/sh−27,410$50,709→ 73,590 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001976640
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:11 PM ET
- Size
- 4.5 KB